星昊医药
(920017)
| 流通市值：19.83亿 | | | 总市值：20.05亿 |
| 流通股本：1.23亿 | | | 总股本：1.25亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 499,078,468.47 | 314,456,566.52 | 158,348,371.9 | 650,139,997.82 |
| 营业总成本 | 396,517,488.5 | 268,138,160.67 | 130,347,236.65 | 542,987,849.51 |
| 其他经营收益 | | | | |
| 营业利润 | 126,029,332.95 | 59,861,682 | 36,161,762.34 | 117,421,542.41 |
| 利润总额 | 124,092,944.83 | 58,129,095.7 | 36,111,762.34 | 117,937,192.91 |
| 净利润 | 110,250,491.8 | 53,240,074.09 | 31,788,942.07 | 103,044,799.11 |
| 每股收益 | | | | |
| 其他综合收益 | -617,625.04 | -723,739.64 | -1,172.31 | -3,828,310.05 |
| 综合收益总额 | 109,632,866.76 | 52,516,334.45 | 31,787,769.76 | 99,216,489.06 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,086,557,913.98 | 1,045,213,987.36 | 1,093,849,537.18 | 1,053,842,841.78 |
| 非流动资产: | | | | |
| 非流动资产合计 | 946,385,156.3 | 935,050,286.83 | 937,324,456.62 | 918,853,224.64 |
| 资产总计 | 2,032,943,070.28 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 |
| 流动负债: | | | | |
| 流动负债合计 | 211,288,815.55 | 225,614,409.36 | 221,288,194.97 | 202,684,876.92 |
| 非流动负债: | | | | |
| 非流动负债合计 | 124,892,073.41 | 122,253,886.82 | 124,586,132.9 | 116,499,293.33 |
| 负债合计 | 336,180,888.96 | 347,868,296.18 | 345,874,327.87 | 319,184,170.25 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,696,762,181.32 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 |
| 股东权益合计 | 1,696,762,181.32 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 |
| 负债和股东权益合计 | 2,032,943,070.28 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 578,534,091.49 | 369,954,991.74 | 190,765,342.74 | 731,361,118.45 |
| 经营活动现金流出小计 | 411,468,499.77 | 257,750,687.66 | 118,404,947.57 | 557,137,111.83 |
| 经营活动产生的现金流量净额 | 167,065,591.72 | 112,204,304.08 | 72,360,395.17 | 174,224,006.62 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 883,888,264.68 | 510,128,184.95 | 339,137,825.61 | 931,694,232.52 |
| 投资活动现金流出小计 | 1,119,473,046.72 | 654,283,304.78 | 451,867,523.66 | 1,105,250,889.35 |
| 投资活动产生的现金流量净额 | -235,584,782.04 | -144,155,119.83 | -112,729,698.05 | -173,556,656.83 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 19,328,180.02 | 10,571,006.94 | 0 | 39,522,340.78 |
| 筹资活动现金流出小计 | 83,472,759.1 | 80,101,749.3 | 58,750 | 20,500,312.6 |
| 筹资活动产生的现金流量净额 | -64,144,579.08 | -69,530,742.36 | -58,750 | 19,022,028.18 |
| 汇率变动对现金及现金等价物的影响 | -1,037,226.64 | -795,614.18 | -524,448.8 | 964,379.32 |
| 现金及现金等价物净增加额 | -133,700,996.04 | -102,277,172.29 | -40,952,501.68 | 20,653,757.29 |
| 期末现金及现金等价物余额 | 300,882,248.64 | 332,306,072.39 | 405,252,906.44 | 434,583,244.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -102,277,172.29 | - | 20,653,757.29 |